| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 70, 328-335, Copyright © 1990 by Endocrine Society
ARTICLES |
JE Hall, RW Whitcomb, JE Rivier, WW Vale and WF Crowley Jr
Reproductive Endocrine Unit, Massachusetts General Hospital, Boston 02114.
To examine the differential regulation of glycoprotein hormone secretion from the gonadotrope by GnRH, the Nal-Glu GnRH antagonist was administered to euthyroid women in the early follicular phase (days 1- 5) of the menstrual cycle, and the results compared to previous studies with the Nal-Arg GnRH antagonist. After a 4-h period of baseline sampling at a frequency of every 10 min, a single sc dose of the GnRH antagonist was administered to each subject. Frequent sampling continued for 8 h, followed by hourly sampling for a further 16 h. LH, FSH, and free alpha-subunit were measured serially in assays with high specificity. There was a 90% concordance of LH and free alpha-subunit pulses during the baseline sampling period. Pulsatile secretion of LH and free alpha-subunit was immediately abolished at the highest dose of the Nal-Glu antagonist for at least 8 h. The maximum percent suppression of LH after administration of the Nal-Glu GnRH antagonist was 70 +/- 4%, 80 +/- 4%, and 83 +/- 1% at doses of 15, 50, and 150 micrograms/kg, respectively, compared to 51 +/- 10%, 70 +/- 5%, and 69 +/- 5% at doses of 50, 150, and 500 micrograms/kg Nal-Arg antagonist. Decreases in FSH were 28 +/- 2%, 32 +/- 7%, and 39 +/- 2%, with increasing doses of the Nal-Glu antagonist compared with 25 +/- 6%, 17 +/- 6%, and 28 +/- 4% reductions at increasing doses of the Nal-Arg antagonist. Free alpha-subunit decreased 22 +/- 4%, 23 +/- 4%, and 28 +/- 3% at increasing doses of the Nal-Glu antagonist and 12 +/- 4%, 27 +/- 4%, and 30 +/- 7% with increasing doses of the Nal-Arg antagonist. For the Nal-Glu antagonist, suppression of LH was greater than that of FSH and free alpha-subunit at all doses (P less than 0.001), while FSH suppression was greater than that of free alpha-subunit at the highest dose only (P less than 0.05). For the Nal-Arg antagonist, LH suppression was greater than that of FSH or free alpha-subunit at all doses (P greater than 0.01), and FSH suppression exceeded that of free alpha-subunit at the 50 micrograms/kg dose. Suppression of LH was greater with the Nal-Glu antagonist than with the Nal-Arg antagonist at doses of 50 and 150 micrograms/kg (P less than 0.05), and FSH suppression was greater with the Nal-Glu antagonist at 150 micrograms/kg (P less than 0.01), while the degrees of maximum suppression were similar for the two different GnRH antagonists for free alpha-subunit.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
![]() |
H. B. Lavoie, E. E. Marsh, and J. E. Hall Absence of Apparent Circadian Rhythms of Gonadotropins and Free {alpha}-Subunit in Postmenopausal Women: Evidence for Distinct Regulation Relative to Other Hormonal Rhythms J Biol Rhythms, February 1, 2006; 21(1): 58 - 67. [Abstract] [PDF] |
||||
![]() |
S. Gill, J. L. Sharpless, K. Rado, and J. E. Hall Evidence That GnRH Decreases with Gonadal Steroid Feedback but Increases with Age in Postmenopausal Women J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2290 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Couzinet, J. Pantel, P. Chanson, J. Young, S. Brailly, I. T. Huhtaniemi, J.-M. Bidart, and G. Schaison Measurement of Plasma Free Luteinizing Hormone {beta}-Subunit in Women J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2293 - 2298. [Abstract] [Full Text] |
||||
![]() |
J. E. Hall, H. B. Lavoie, E. E. Marsh, and K. A. Martin Decrease in Gonadotropin-Releasing Hormone (GnRH) Pulse Frequency with Aging in Postmenopausal Women J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1794 - 1800. [Abstract] [Full Text] |
||||
![]() |
J. Oberye, B. Mannaerts, J. Huisman, and C. Timmer Local tolerance, pharmacokinetics, and dynamics of ganirelix (Orgalutran(R)) administration by Medi-Jector(R) compared to conventional needle injections Hum. Reprod., February 1, 2000; 15(2): 245 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, J. M. Adams, P. M. Sluss, and J. E. Hall Inhibin A and Inhibin B Responses to Gonadotropin Withdrawal Depends on Stage of Follicle Development J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2163 - 2169. [Abstract] [Full Text] |
||||
![]() |
F. J. Hayes, D. J. McNicholl, D. Schoenfeld, E. E. Marsh, and J. E. Hall Free {alpha}-Subunit Is Superior to Luteinizing Hormone as a Marker of Gonadotropin-Releasing Hormone Despite Desensitization at Fast Pulse Frequencies J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1028 - 1036. [Abstract] [Full Text] |
||||
![]() |
S. B. Seminara, F. J. Hayes, and W. F. Crowley Jr. Gonadotropin-Releasing Hormone Deficiency in the Human (Idiopathic Hypogonadotropic Hypogonadism and Kallmann's Syndrome): Pathophysiological and Genetic Considerations Endocr. Rev., October 1, 1998; 19(5): 521 - 539. [Abstract] [Full Text] |
||||
![]() |
F. J. Hayes, A. E. Taylor, K. A. Martin, and J. E. Hall Use of a Gonadotropin-Releasing Hormone Antagonist as a Physiologic Probe in Polycystic Ovary Syndrome: Assessment of Neuroendocrine and Androgen Dynamics J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2343 - 2349. [Abstract] [Full Text] |
||||
![]() |
H. B. Lavoie, K. A. Martin, A. E. Taylor, W. F. Crowley, and J. E. Hall Exaggerated Free {alpha}-Subunit Levels during Pulsatile Gonadotropin-Releasing Hormone Replacement in Women with Idiopathic Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 241 - 247. [Abstract] [Full Text] |
||||
![]() |
K. Albertsson-Wikland, S. Rosberg, B. Lannering, L. Dunkel, G. Selstam, and E. Norjavaara Twenty-Four-Hour Profiles of Luteinizing Hormone, Follicle-Stimulating Hormone, Testosterone, and Estradiol Levels: A Semilongitudinal Study throughout Puberty in Healthy Boys J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 541 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Padmanabhan, K. McFadden, D. T. Mauger, F. J. Karsch, and A. R. Midgley Jr. Neuroendocrine Control of Follicle-Stimulating Hormone (FSH) Secretion. I. Direct Evidence for Separate Episodic and Basal Components of FSH Secretion Endocrinology, January 1, 1997; 138(1): 424 - 432. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |